Senda Biosciences
Sail Biomedicines is at the forefront of programmable medicines, leveraging AI and a proprietary bioplatform to create life-changing treatments. Their core technology revolves around Endless RNA (eRNA), a circular RNA that allows for prolonged and programmable protein expression within the body, offering enhanced durability against degradation. Complementing this is their work in programmable nanoparticles, designed using a broad range of natural chemistries for improved deployment and tropism. Sail integrates these technologies with generative AI and rapid prototyping to design novel RNA medicines aimed at treating a spectrum of diseases including autoimmune, metabolic, infectious, and rare diseases.
Senda Biosciences
Sail Biomedicines is at the forefront of programmable medicines, leveraging AI and a proprietary bioplatform to create life-changing treatments. Their core technology revolves around Endless RNA (eRNA), a circular RNA that allows for prolonged and programmable protein expression within the body, offering enhanced durability against degradation. Complementing this is their work in programmable nanoparticles, designed using a broad range of natural chemistries for improved deployment and tropism. Sail integrates these technologies with generative AI and rapid prototyping to design novel RNA medicines aimed at treating a spectrum of diseases including autoimmune, metabolic, infectious, and rare diseases.